Searchable abstracts of presentations at key conferences in endocrinology

ea0099p298 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Current prevalence and patterns of hypolipidemic medication based on real-life nation-wide data on 10, 816, 286 individuals

Mathioudakis Konstantinos , Yavropoulou Maria , Evangelia Koloutsou Maria , Makras Polyzois , Liberopoulos Evangelos , Athanasakis Konstantinos

Background: Hypercholesterolemia has an established causal role in the progression of atherosclerosis and development of cardiovascular disease (CVD). In studies carried out after 2002, the estimated prevalence of self-reported dyslipidemia in the Greek population ranges from 11% to 23%, whereas approximately 35% of mortality in Greece is attributed to cardiovascular disease (CVD). Relevant real-life data, however, are scarce.Methods: In the present stud...

ea0081rc5.2 | Rapid Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

Anagnostis Panagiotis , Rizos Christos , Skoumas Ioannis , Rallidis Loukianos , Tziomalos Konstantinos , Skalidis Emmanuel , Kotsis Vasileios , Doumas Michalis , Kolovou Genovefa , Sfikas George , Garoufi Anastasia , Lambadiari Vaia , Dima Ioanna , Kiouri Estela , Agapakis Dimitrios , Zacharis Evangelos , Antza Christina , Kolovou Vana , Koumaras Charalambos , Bantouvakis George , Liamis George , Liberopoulos Evangelos

Aims: Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD) in the general population. However, such a role in patients with familial hypercholesterolemia (FH) is less documented. The purpose of this study was to evaluate the association between Lp(a) concentrations and ASCVD prevalence in adult patients with FH.Methods: This was a cross-sectional study from the Hellenic Familial Hypercholesterolemia Regi...